This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $28.47, marking a +0.46% move from the previous day.
Omega Healthcare Investors (OHI) Misses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of -6.10% and 7%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare Investors (OHI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $30.31, marking a -0.26% move from the previous day.
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $31.63, marking a +1.48% move from the previous day.
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $31.28, moving +0.48% from the previous trading session.
Omega Healthcare Investors (OHI) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $30.40, moving -0.1% from the previous trading session.
Omega Healthcare Investors (OHI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $30.43, marking a +1.16% move from the previous day.
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $29.31, marking a +0.55% move from the previous day.
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $28.33, marking a +0.18% move from the previous day.
Omega Healthcare Investors (OHI) Stock Moves -0.68%: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $27.61 in the latest trading session, marking a -0.68% move from the prior day.
Omega Healthcare Investors (OHI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $28.01, moving -1.27% from the previous trading session.
Omega Healthcare Investors (OHI) Beats Q3 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 3.66% and 4.31%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare Investors (OHI) Q2 FFO Surpass Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 2.41% and -3.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare Investors (OHI) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Omega Healthcare Investors (OHI) Q1 FFO and Revenues Top Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 3.66% and 4.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Omega (OHI) This Earnings Season?
by Zacks Equity Research
Omega (OHI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Omega Healthcare Investors (OHI) Q4 FFO Match Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 0.00% and 3.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Four Corners on Buyout Spree, Acquires 2 Seritage Properties
by Zacks Equity Research
Four Corners' (FCPT) acquisitions are part of its efforts to capitalize on solid acquisition opportunities, backed by balance-sheet strength, and boost the company's portfolio growth.
Lamar (LAMR) to Raise 146.9M With Private Placement of Notes
by Zacks Equity Research
Lamar (LAMR) resorts to debt financing with a $150-million senior unsecured notes offering. The proceeds from the offering will be used to address near-term debt maturities.
Pebblebrook (PEB) Provides Operating Trend Update for Q3
by Zacks Equity Research
Continued hotel openings in the third quarter enable Pebblebrook (PEB) to reduce monthly hotel portfolio cash burn by $6 million from the May estimate.
Is it Wise to Hold On to PS Business Parks (PSB) Stock Now?
by Zacks Equity Research
PS Business Parks (PSB) will likely gain from its diversified portfolio, asset-repositioning moves and balance-sheet strength though a sluggish economy and rent-collection woes are concerns.
Lexington Realty Prices $400M of Senior Notes at 99.233%
by Zacks Equity Research
Lexington Realty (LXP) to boost liquidity and address near-term debt maturities with a senior unsecured notes offering.
LGI Homes (LGIH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
LGI Homes (LGIH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Top Ranked Income Stocks to Buy for June 30th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, June 30th
Omega Healthcare Investors (OHI) Q1 FFO and Revenues Top Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 3.95% and 0.93%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?